Crotedumab (REGN1193) (INN) is a humanized monoclonal antibody designed for the treatment of diabetes.Statement On A Nonproprietary Name Adopted By The USAN Council…
Crotedumab (REGN1193) (INN) is a humanized monoclonal antibody designed for the treatment of diabetes.Statement On A Nonproprietary Name Adopted By The USAN Council - Crotedumab, American Medical Association.
This drug was developed by Regeneron Pharmaceuticals but is no longer under development.
References
Gebaseerd op: Wikipedia — Crotedumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.